metoclopramide has been researched along with procainamide in 30 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (26.67) | 18.7374 |
1990's | 4 (13.33) | 18.2507 |
2000's | 11 (36.67) | 29.6817 |
2010's | 7 (23.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Erhardt, PW; Hanna, RG; Lampe, JW; Lumma, WC; Sullivan, ME; Wong, SS | 1 |
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Alagna, S; Delitala, G; Devilla, L; Masala, A | 1 |
Cheymol, G; Mouillé, P | 1 |
Bateman, DN | 1 |
Angrist, BM | 1 |
Fontaine, J; Reuse, J | 1 |
Brambilla, G; Campart, GB; Canonero, R; Martelli, A; Mattioli, F | 1 |
Allavena, A; Brambilla, G; Ghia, M; Martelli, A; Mereto, E; Robbiano, L | 1 |
Hua, J; Pero, RW | 1 |
Hua, J; Kane, R; Pero, RW | 1 |
Leanderson, T; Lindgren, H; Olsson, AR; Pero, RW | 1 |
CASTERA, R; CORNET, A; ECOIFFIER, J; GRIVAUX, M; GUERRE, J; JUSTIN-BESANCON, L; WATTEZ, E | 1 |
BOISSIER, JR; FICHELLE-PAGNY, J; LWOFF, JM; SIMON, P | 1 |
2 review(s) available for metoclopramide and procainamide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacokinetics and metabolism of the benzamides.
Topics: Acecainide; Animals; Benzamides; Disease; Half-Life; Humans; Kinetics; Metoclopramide; Procainamide; Sulpiride | 1982 |
28 other study(ies) available for metoclopramide and procainamide
Article | Year |
---|---|
Heterocyclic analogues of benzamide antiarrhythmic agents.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Benzamides; Chemical Phenomena; Chemistry; Dogs; Electrophysiology; In Vitro Techniques; Papillary Muscles; Purkinje Fibers; Structure-Activity Relationship | 1989 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Plasma prolactin response to L-dopa TRH and metaclopramide in thyrotoxicosis.
Topics: Female; Humans; Hyperthyroidism; Injections, Intravenous; Levodopa; Male; Metoclopramide; Procainamide; Prolactin | 1976 |
[Cardiovascular and hemodynamic effects of derivatives of metoclopramide].
Topics: Animals; Blood Pressure; Cholinesterase Inhibitors; Dogs; Electrocardiography; Female; Heart Rate; Hemodynamics; Male; Metoclopramide; Myocardial Contraction; Procainamide; Respiration; Vascular Resistance | 1975 |
The neurobiologically active benzamides and related compounds: some historical aspects.
Topics: Benzamides; Chlorpromazine; Haloperidol; History, 20th Century; Humans; Metoclopramide; Nervous System; Procainamide; Sulpiride | 1982 |
The effects of substituted benzamides on frog rectus abdominis.
Topics: Amisulpride; Animals; Benzamides; Cholinesterase Inhibitors; In Vitro Techniques; Metoclopramide; Muscles; Procainamide; Rana esculenta; Sulpiride; Tiapamil Hydrochloride | 1980 |
Testing of metoclopramide and procainamide for their ability to induce genotoxic effects in cultured mammalian cells.
Topics: Animals; Autoradiography; Cells, Cultured; Cricetinae; Cricetulus; DNA Repair; DNA, Single-Stranded; Humans; Liver; Lung; Lymphocytes; Male; Metoclopramide; Micronuclei, Chromosome-Defective; Mutagenicity Tests; Mutagens; Procainamide; Rats; Rats, Sprague-Dawley | 1995 |
Evaluation of DNA-damaging, clastogenic, and promoting activities of metoclopramide and procainamide in rats.
Topics: Administration, Oral; Animals; Carcinogens; DNA; Liver; Male; Metoclopramide; Micronucleus Tests; Mutagens; Nitroso Compounds; Procainamide; Rats; Rats, Sprague-Dawley | 1995 |
Toxicity, antitumor and chemosensitizing effects of 3-chloroprocainamide.
Topics: Animals; Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Drug Interactions; Drug Screening Assays, Antitumor; Female; Humans; Male; Metoclopramide; Mice; Mice, SCID; Neoplasm Transplantation; Procainamide; Transplantation, Heterologous | 1997 |
Pharmacokinetics and central nervous system toxicity of declopramide (3-chloroprocainamide) in rats and mice.
Topics: Administration, Oral; Animals; Antiemetics; Biological Availability; Central Nervous System; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Metoclopramide; Mice; Mice, SCID; Procainamide; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Sleep Stages; Tissue Distribution | 1999 |
Mechanism of action for N-substituted benzamide-induced apoptosis.
Topics: Apoptosis; Benzamides; Caspase 9; Caspases; Cytochrome c Group; Enzyme Activation; G2 Phase; HL-60 Cells; Humans; Metoclopramide; Mitosis; Procainamide; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Protein p53 | 2002 |
[SENSORIMOTOR DISTURBANCES IN DUODENAL ULCER. RADIOLOGIC TEST AND COURSE UNDER METOCLOPRAMIDE].
Topics: Antiemetics; Atropine; Drug Therapy; Duodenal Ulcer; Gastrointestinal Motility; Humans; Metoclopramide; Procainamide; Radiography | 1964 |
[PSYCHOLEPTIC ACTION OF METOCLOPRAMIDE].
Topics: Acetylcholine; Antiemetics; Apomorphine; Barbiturates; Behavior, Animal; Blood Pressure; Blood Pressure Determination; Dogs; Epinephrine; Humans; Male; Metoclopramide; Mice; Norepinephrine; Pharmacology; Procainamide; Psychopharmacology; Rats; Research; Seminal Vesicles; Toxicology | 1964 |